- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterOncoLink at ASCO 2001: Tuesday, May 15
 |
| A short break from the busy schedule to see the Redwoods. |
|
American Cancer Society Award Winner Sidney Winawer, MD, Discusses the Progress and Promise of Colorectal Cancer Screening
"The best screening test is the screening test that gets done." That was the central point repeatedly made by Sidney Winawer, MD, Chief of Gastroenterology at Memorial Sloan Kettering Cancer Center, as he sketched out a twenty-five year... |
|
|
Bone Mineral Density In Premenopausal Patients In A Randomized Trial Of Adjuvant Endocrine Therapy (ZIPP-TRIAL)
Presenter: Asgerdur Sverrisdóttir Affiliation: University Hospital, Stockholm, Sweden Background: There is evidence that ovarian ablation can improve survival in pre-menopausal patients with early-stage breast cancer. However, there is ... |
|
|
Clinical Significance Of Axillary Micrometastases In Breast Cancer: How Small Is Too Small?
Presenter: Nora M Hansen Affiliation: John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA Background: Lymph node metastases are the most significant prognostic indicator for patients with breast cancer. a. 15-20% LN ?... |
|
|
Comparison Of Lumpectomy Plus Tamoxifen With And Without Radiotherapy (RT) In Women 70 Years Of Age Or Older Who Have Clinical Stage I, Estrogen Receptor Positive (ER+) Breast Carcinoma
Presenter: Kevin S. Hughes Affiliation: Massachusetts General Hospital Background: No survival impact of RT from previous studies. Tumor in this group of pts grow slowly, therefore, less time at risk. This study is designed to assess, in this... |
|
|
Effect Of Raloxifene After Tamoxifen On Breast And Endometrial Cancer Growth
Presenter: Ruth M. O'Regan Affiliation: Northwestern University, Chicago, IL Background: After the completion of 5 years of tamoxifen therapy, breast cancer patients are still at risk for osteoporosis and breast cancer recurrence. Raloxifene... |
|
|
Incidence And Prognostic Impact Of Amenorrhea During Adjuvant Therapy In High Risk Premenopausal Breast Cancer Patients: Analysis Of A National Cancer Institute Of Canada Clinical Trials Group (NCIC CTG) Phase III Study
Presenter: W. Parulekar Affiliation: Kingston, ON, Canada Background: One of the consequences of adjuvant therapy for breast cancer is drug-induced amenorrhea. The incidence and prognostic impact of drug induced amenorrhea (DIA) during... |
|
|
Overall Survival After Cyclophosphamide, Adriamycin, 5-FU, And Tamoxifen (CAFT) Is Superior To T Alone In Postmenopausal, Receptor (+), Node (+) Breast Cancer: New Findings From Phase III Southwest Oncology Group Intergroup Trial S8814 (INT-0100)
Presenter: Kathy Albain Affiliation: Loyola Univ. Med. Center, Maywood, IL Background: The treatment of older women with breast cancer presents many unique treatment issues. One such issue is the use of anthracyclines to treat older patients... |
|
|
Preliminary Results Of A Randomized Study Of Tamoxifen +/- Breast Radiation In T1/2 N0 Disease In Women Over 50 Years Of Age
Presenter: Anthony Fyles Affiliation: Princess Margaret Hospital, Toronto, ON, Canada Background: Breast radiation (RT) shows definitive reduction in local relapses, however, with moderal toxicity and without a survival benefit. In Tamoxifen... |
|
|
Preventing Chemotherapy-associated Amenorrhea (CRA) With Leuprolide In Young Women With Early-stage Breast Cancer
Presenter: Kevin R. Fox Affiliation: University of Pennsylvania Cancer Center, Philadelphia, PA Background: Premature amenorrhea is often associated with adjuvant chemotherapy treatment for breast cancer. The rate of amenorrhea varies to 10 to... |
|
|
Radiation Therapy Oncology Group (RTOG) 95-14; a phase II study of neoadjuvant chemotherapy (CT) and radiation therapy (RT) in high risk (HR), high grade, soft tissue sarcomas (STS) of the extremities and body wall: a preliminary report
Presenter: W.G.Kraybill Affiliation: RTOG Background: Radiation therapy plays a central role in the management of many soft tissue sarcomas and allows for a substantial reduction in the extent of surgical resection. The addition of ... |
|
|
Response to neoadjuvant thermochemotherapy as significant prognosticator for long-term survival of patients with retroperitoneal or visceral high-risk soft-tissue sarcoma
Presenter: C.M.Wendtner Affiliation: Ludwig-Maximilian-University Background: The clinical application of hyperthermia with increase of tissue temperatures (range 40-44 degrees C) has been integrated in multimodal anti- cancer strategies. The... |
|
|
Second Malignant Neoplasms (SMN) In Children Treated For Rhabdomyosarcoma: A Report From The Intergroup Rhabdomyosarcoma Studies (IRS) I-IV
Presenter: Sheri L. Spunt Affiliation: Children's Oncology Group Soft Tissue Sarcoma Committee, Arcadia, CA Background: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of the childhood (5%). Multimodality therapy can provide cure... |
|
|
Therapy-related Myelodysplasia (T-MDS/T-AML) Following Treatment Of Children With Osteosarcoma
Presenter: Smita Bhatia Affiliation: City of Hope Comprehensive Cancer Center, Duarte, CA Background: T-MDS/T-AML is known to be associated with anti-neoplastic treatment. With alkylating agents, T-MDS/T-AML is associated with deletion of... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
